ProPhase Labs Statistics
Total Valuation
ProPhase Labs has a market cap or net worth of 380,091. The enterprise value is 9.48 million.
| Market Cap | 380,091 |
| Enterprise Value | 9.48M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ProPhase Labs has 14.02 million shares outstanding. The number of shares has increased by 338.97% in one year.
| Current Share Class | 14.02M |
| Shares Outstanding | 14.02M |
| Shares Change (YoY) | +338.97% |
| Shares Change (QoQ) | +13.79% |
| Owned by Insiders (%) | 2.37% |
| Owned by Institutions (%) | 0.00% |
| Float | 13.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| PB Ratio | -0.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.65 |
| Interest Coverage | -2.15 |
Financial Efficiency
Return on equity (ROE) is -539.65% and return on invested capital (ROIC) is -1,600.93%.
| Return on Equity (ROE) | -539.65% |
| Return on Assets (ROA) | -19.56% |
| Return on Invested Capital (ROIC) | -1,600.93% |
| Return on Capital Employed (ROCE) | 2,295.13% |
| Weighted Average Cost of Capital (WACC) | 60.48% |
| Revenue Per Employee | 202,474 |
| Profits Per Employee | -1.18M |
| Employee Count | 19 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 7.12 |
Taxes
In the past 12 months, ProPhase Labs has paid 607,000 in taxes.
| Income Tax | 607,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.13% in the last 52 weeks. The beta is 0.13, so ProPhase Labs's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -99.13% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.45 |
| Relative Strength Index (RSI) | 32.02 |
| Average Volume (20 Days) | 256,936 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ProPhase Labs had revenue of 3.85 million and -22.46 million in losses. Loss per share was -1.71.
| Revenue | 3.85M |
| Gross Profit | 645,000 |
| Operating Income | -15.56M |
| Pretax Income | -21.86M |
| Net Income | -22.46M |
| EBITDA | -11.64M |
| EBIT | -15.56M |
| Loss Per Share | -1.71 |
Balance Sheet
The company has 20,000 in cash and 9.12 million in debt, with a net cash position of -9.10 million or -0.65 per share.
| Cash & Cash Equivalents | 20,000 |
| Total Debt | 9.12M |
| Net Cash | -9.10M |
| Net Cash Per Share | -0.65 |
| Equity (Book Value) | -3.11M |
| Book Value Per Share | -0.22 |
| Working Capital | -55.29M |
Cash Flow
| Operating Cash Flow | -5.54M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 3.93M |
| Net Borrowing | 5.34M |
| Free Cash Flow | -5.54M |
| FCF Per Share | -0.40 |
Margins
| Gross Margin | 16.77% |
| Operating Margin | -404.50% |
| Pretax Margin | -568.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ProPhase Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -338.97% |
| Shareholder Yield | -338.97% |
| Earnings Yield | -5,909.90% |
| FCF Yield | -1,458.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 22, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |